Cowealth Medical China Co.,Ltd. (SHA:603122)

Cowealth Medical China Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	140.34	106.47	260.84	197.89	326.86	146.6
Short-Term Investments	-	42.98	-	-	-	-
Trading Asset Securities	-	-	-	-	10	-
Cash & Short-Term Investments	140.34	149.44	260.84	197.89	336.86	146.6
Cash Growth	-27.36%	-42.71%	31.81%	-41.25%	129.78%	-40.66%
Accounts Receivable	766.79	716.33	746.93	758.84	747.95	557.35
Other Receivables	1.04	1.58	2.15	7.65	4.77	6.89
Receivables	767.83	717.91	749.08	766.49	752.72	564.24
Inventory	162.48	172.64	201.88	196.87	204.82	178.86
Other Current Assets	57.27	84.29	79.18	93.54	116.95	80.14
Total Current Assets	1,128	1,124	1,291	1,255	1,411	969.85
Property, Plant & Equipment	148.4	152.92	118.95	118.53	81.98	88.27
Long-Term Investments	15.72	24.5	-	-	-	-
Other Intangible Assets	5.88	7	7.48	7.89	1.81	0.94
Long-Term Deferred Tax Assets	48.37	44.78	29.99	34.3	31.79	29.06
Long-Term Deferred Charges	39.54	18.73	21.9	17.78	13.82	23.43
Other Long-Term Assets	53.5	55.26	22.63	24	15.63	5.96
Total Assets	1,439	1,429	1,494	1,461	1,559	1,121

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	322.98	266.4	224.12	167.67	240.09	127.8
Accrued Expenses	9.02	11.39	14.85	43.4	40.11	37.82
Short-Term Debt	32.61	57.07	46.27	53.92	51.31	97.64
Current Portion of Long-Term Debt	2.02	1.48	2.22	8.84	8.69	10.15
Current Portion of Leases	-	0.72	1.34	2.51	3.44	3.41
Current Income Taxes Payable	2.87	1.15	5.11	7.08	14.56	13.99
Current Unearned Revenue	2.62	0.49	1.61	1.14	2.04	9.12
Other Current Liabilities	24.38	28.19	23.18	1.16	1.32	1.67
Total Current Liabilities	396.49	366.88	318.7	285.73	361.55	301.61
Long-Term Debt	0.73	1.9	-	2.18	10.84	11.99
Long-Term Leases	0.24	0.12	0.74	3.5	5.71	7.91
Other Long-Term Liabilities	-	-	-	1.08	2.38	3.28
Total Liabilities	397.45	368.9	319.44	292.49	380.49	324.78

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	398.05	398.05	398.05	398.05	398.05	298.54
Additional Paid-In Capital	596.74	596.74	596.62	596.65	596.65	336.1
Retained Earnings	79.73	85.37	170.76	167.08	179.6	168.53
Comprehensive Income & Other	-35.07	-22.28	6.03	5.02	3.44	-7.33
Total Common Equity	1,039	1,058	1,171	1,167	1,178	795.83
Minority Interest	2.42	1.74	3.16	2.11	0.83	-0.07
Shareholders' Equity	1,042	1,060	1,175	1,169	1,179	795.77
Total Liabilities & Equity	1,439	1,429	1,494	1,461	1,559	1,121

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	35.59	61.29	50.57	70.96	80	131.1
Net Cash (Debt)	104.75	88.16	210.28	126.93	256.86	15.5
Net Cash Growth	-37.37%	-58.08%	65.66%	-50.58%	1556.84%	-88.19%
Net Cash Per Share	0.26	0.21	0.53	0.32	0.68	0.05
Filing Date Shares Outstanding	441.63	398.05	398.05	398.05	398.05	398.05
Total Common Shares Outstanding	441.63	398.05	398.05	398.05	398.05	298.54
Working Capital	731.43	757.41	972.28	969.07	1,050	668.24
Book Value Per Share	2.35	2.66	2.94	2.93	2.96	2.67
Tangible Book Value	1,034	1,051	1,164	1,159	1,176	794.89
Tangible Book Value Per Share	2.34	2.64	2.92	2.91	2.95	2.66
Buildings	-	127.69	127.69	122.07	80.07	78.78
Machinery	-	47.89	57.95	67.42	83.41	86.82
Construction In Progress	-	39.51	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error